Trials / Completed
CompletedNCT01946243
The Feasibility of Florbetapir Quantitation
The Feasibility and Reliability of Utilizing Commercially Available Quantitative Analysis Software as an Adjunct to the Clinical Qualitative Interpretation of Amyvid Brain Scans
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The overall objective of the study is to assess the feasibility of implementing a quantitative process of florbetapir F 18 scan interpretation. The hypothesis is that the use of quantitative analysis will increase the accuracy of florbetapir F 18 scan interpretation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Florbetapir F18 | No Florbetapir F 18 will be administered in this study. |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2013-09-19
- Last updated
- 2015-06-29
- Results posted
- 2015-06-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01946243. Inclusion in this directory is not an endorsement.